what drug is glp 1 The GLP-1 revolution: UAB researchers are discovering about how these drugs work Market Overview: GLP-1 Agonists and

Trillenberg P, Sprenger A, Machner B

Cost effectiveness of sodium-glucose cotransporter-2 (SGLT2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and dipeptidyl peptidase-4 (DPP-4) inhibitors: a systematic review

This is one of the most common reasons patients transition between these medications

Patients using GLP-1RAs should maintain a diet rich in healthy proteins and whole foods while avoiding ultra-processed foods, especially in those with frailty

Coexisting conditions affecting the tumor risk of GLP-1RAs Metabolic diseases Large-scale clinical studies have confirmed that the use of GLP-1RAs in diabetic populations does not increase the cancer risk occurrence